グローバル組換えタンパク質市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Recombinant Proteins - Global Top Players Market Share and Ranking 2026
  • レポートID:
    61616
  • 発表時期:
    2026-01-07
  • レポート形式:
    PDF
  • 産業カテゴリー:
    薬品及びサプリメント
  • レポート言語:
    英語、日本語
  • ページ数:
    109
  • 発行会社(調査会社):
    YHResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=162.40円

※米ドル表示価格+10%消費税。

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界の組換えタンパク質市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から組換えタンパク質市場を分析し、需要構造と成長特性を明確化します。
組換えタンパク質市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、組換えタンパク質に関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要組換えタンパク質市場の統計
2025年世界市場規模:1478百万米ドル
2026年世界市場規模:1651百万米ドル
2032年予測市場規模:3297百万米ドル
2026–2032年予測期間CAGR:12.2%
本レポートは組換えタンパク質市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
組換えタンパク質市場の主要企業には以下が含まれます:
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto

製品別
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others

アプリケーション別
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations

レポート対象地域
北米:アメリカ、カナダ、その他
アジア太平洋:中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ:メキシコ、ブラジル、その他
中東・アフリカ:トルコ、サウジアラビア、UAE、その他

レポート構成(章別概要)
第1章|市場概要と成長展望
組換えタンパク質市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章|主要企業の競争分析
組換えタンパク質市場における主要プレイヤー(トップ5社・トップ10社)を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章|製品カテゴリ別市場動向
製品タイプ別に組換えタンパク質市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章|用途別市場動向
用途別に組換えタンパク質市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章|地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、組換えタンパク質市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章|国別市場動向
主要国・地域ごとに、組換えタンパク質市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章|主要企業プロファイル
組換えタンパク質市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章|バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章|調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章|付録(調査手法・データソース)
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 組換えタンパク質市場の全体像と成長見通し
組換えタンパク質市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が組換えタンパク質市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
組換えタンパク質産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
組換えタンパク質市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から組換えタンパク質市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
組換えタンパク質市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
組換えタンパク質市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
title

Description

According to YH Research, the global market for Recombinant Proteins should grow from US$ 1478 million in 2025 to US$ 3297 million by 2032, with a CAGR of 12.2% for the period of 2026-2032.

Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.

This report studies and analyses global Recombinant Proteins status and future trends, to help determine the Recombinant Proteins market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Recombinant Proteins, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Recombinant Proteins market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Recombinant Proteins by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Recombinant Proteins by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Recombinant Proteins key consuming regions, consumption value and demand structure
(5) Recombinant Proteins industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto

Market segment by Type, covers
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others

Market segment by Application, can be divided into
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Recombinant Proteins product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Recombinant Proteins market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Recombinant Proteins market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Recombinant Proteins industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions
title

Table of Contents

1 Market Overview
1.1 Recombinant Proteins Definition
1.2 Global Recombinant Proteins Market Size and Forecast
1.3 Japan Recombinant Proteins Market Size and Forecast
1.4 Share of Japan Recombinant Proteins Market with Respect to the Global Market
1.5 Recombinant Proteins Market Size: Japan VS Global Growth Rate, 2021-2032
1.6 Recombinant Proteins Market Dynamics
1.6.1 Recombinant Proteins Market Drivers
1.6.2 Recombinant Proteins Market Restraints
1.6.3 Recombinant Proteins Industry Trends
1.6.4 Recombinant Proteins Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Recombinant Proteins, Global Market Share by Company, 2021-2026
2.2 Global Recombinant Proteins Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Recombinant Proteins Concentration Ratio
2.4 Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
2.5 Global Recombinant Proteins Major Companies Product Type
2.6 Head Office and Area Served of Key Players
3 Japan Leading Players, Market Share and Ranking
3.1 By Revenue of Recombinant Proteins, Japan Market Share by Company, 2021-2026
3.2 Japan Recombinant Proteins Recombinant Proteins Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Recombinant Proteins Industry Chain
4.2 Recombinant Proteins Upstream Analysis
4.2.1 Recombinant Proteins Core Raw Materials
4.2.2 Main Manufacturers of Recombinant Proteins Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Recombinant Proteins Production Mode
4.6 Recombinant Proteins Procurement Model
4.7 Recombinant Proteins Industry Sales Model and Sales Channels
4.7.1 Recombinant Proteins Sales Model
4.7.2 Recombinant Proteins Typical Distributors
5 Sights by Type
5.1 Recombinant Proteins Classification by Type
5.1.1 Hormones
5.1.2 Growth Factors
5.1.3 Cytokines
5.1.4 Plasma Protein Factor
5.1.5 Recombinant Metabolic Enzymes
5.1.6 Immune Checkpoint Regulators
5.1.7 Others
5.2 by Type, Global Recombinant Proteins Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.3 by Type, Global Recombinant Proteins Consumption Value, 2021-2032
6 Sights by Application
6.1 Recombinant Proteins Segment by Application
6.1.1 Biopharmaceutical Companies
6.1.2 Academic and Research Institutes
6.1.3 Contract Research Organizations
6.2 by Application, Global Recombinant Proteins Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Application, Global Recombinant Proteins Consumption Value, 2021-2032
7 Sales Sights by Region
7.1 By Region, Global Recombinant Proteins Consumption Value, 2021 VS 2025 VS 2032
7.2 By Region, Global Recombinant Proteins Consumption Value, 2021-2032
7.3 North America
7.3.1 North America Recombinant Proteins Market Size & Forecasts, 2021-2032
7.3.2 By Country, North America Recombinant Proteins Market Size Market Share
7.4 Europe
7.4.1 Europe Recombinant Proteins Market Size & Forecasts, 2021-2032
7.4.2 By Country, Europe Recombinant Proteins Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Recombinant Proteins Market Size & Forecasts, 2021-2032
7.5.2 By Country/Region, Asia Pacific Recombinant Proteins Market Size Market Share
7.6 South America
7.6.1 South AmericaRecombinant Proteins Market Size & Forecasts, 2021-2032
7.6.2 By Country, South America Recombinant Proteins Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Recombinant Proteins Market Size & CAGR, 2021 VS 2025 VS 2032
8.2 By Country, Global Recombinant Proteins Consumption Value, 2021-2032
8.3 United States
8.3.1 United States Recombinant Proteins Market Size, 2021-2032
8.3.2 by Type, United States Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.3.3 by Application, United States Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.4 Europe
8.4.1 Europe Recombinant Proteins Market Size, 2021-2032
8.4.2 by Type, Europe Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.4.3 by Application, Europe Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.5 China
8.5.1 China Recombinant Proteins Market Size, 2021-2032
8.5.2 by Type, China Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.5.3 by Application, China Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.6 Japan
8.6.1 Japan Recombinant Proteins Market Size, 2021-2032
8.6.2 by Type, Japan Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.6.3 by Application, Japan Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.7 South Korea
8.7.1 South Korea Recombinant Proteins Market Size, 2021-2032
8.7.2 by Type, South Korea Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.7.3 by Application, South Korea Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.8 Southeast Asia
8.8.1 Southeast Asia Recombinant Proteins Market Size, 2021-2032
8.8.2 by Type, Southeast Asia Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.8.3 by Application, Southeast Asia Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.9 India
8.9.1 India Recombinant Proteins Market Size, 2021-2032
8.9.2 by Type, India Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.9.3 by Application, India Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.10 Middle East & Africa
8.10.1 Middle East & Africa Recombinant Proteins Market Size, 2021-2032
8.10.2 by Type, Middle East & Africa Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
8.10.3 by Application, Middle East & Africa Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
9 Company Profile
9.1 Bio-Techne Corporation
9.1.1 Bio-Techne Corporation Company Information, Head Office, Market Area, and Industry Position
9.1.2 Bio-Techne Corporation Company Profile and Main Business
9.1.3 Bio-Techne Corporation Recombinant Proteins Models, Specifications, and Application
9.1.4 Bio-Techne Corporation Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.1.5 Bio-Techne Corporation Recent Developments
9.2 Abcam PLC
9.2.1 Abcam PLC Company Information, Head Office, Market Area, and Industry Position
9.2.2 Abcam PLC Company Profile and Main Business
9.2.3 Abcam PLC Recombinant Proteins Models, Specifications, and Application
9.2.4 Abcam PLC Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.2.5 Abcam PLC Recent Developments
9.3 Merck KGaA
9.3.1 Merck KGaA Company Information, Head Office, Market Area, and Industry Position
9.3.2 Merck KGaA Company Profile and Main Business
9.3.3 Merck KGaA Recombinant Proteins Models, Specifications, and Application
9.3.4 Merck KGaA Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.3.5 Merck KGaA Recent Developments
9.4 Miltenyi Biotec
9.4.1 Miltenyi Biotec Company Information, Head Office, Market Area, and Industry Position
9.4.2 Miltenyi Biotec Company Profile and Main Business
9.4.3 Miltenyi Biotec Recombinant Proteins Models, Specifications, and Application
9.4.4 Miltenyi Biotec Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.4.5 Miltenyi Biotec Recent Developments
9.5 Thermo Fisher Scientific
9.5.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
9.5.2 Thermo Fisher Scientific Company Profile and Main Business
9.5.3 Thermo Fisher Scientific Recombinant Proteins Models, Specifications, and Application
9.5.4 Thermo Fisher Scientific Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.5.5 Thermo Fisher Scientific Recent Developments
9.6 ACROBiosystems
9.6.1 ACROBiosystems Company Information, Head Office, Market Area, and Industry Position
9.6.2 ACROBiosystems Company Profile and Main Business
9.6.3 ACROBiosystems Recombinant Proteins Models, Specifications, and Application
9.6.4 ACROBiosystems Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.6.5 ACROBiosystems Recent Developments
9.7 Sino Biological
9.7.1 Sino Biological Company Information, Head Office, Market Area, and Industry Position
9.7.2 Sino Biological Company Profile and Main Business
9.7.3 Sino Biological Recombinant Proteins Models, Specifications, and Application
9.7.4 Sino Biological Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.7.5 Sino Biological Recent Developments
9.8 Cytiva
9.8.1 Cytiva Company Information, Head Office, Market Area, and Industry Position
9.8.2 Cytiva Company Profile and Main Business
9.8.3 Cytiva Recombinant Proteins Models, Specifications, and Application
9.8.4 Cytiva Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.8.5 Cytiva Recent Developments
9.9 Eurogentec
9.9.1 Eurogentec Company Information, Head Office, Market Area, and Industry Position
9.9.2 Eurogentec Company Profile and Main Business
9.9.3 Eurogentec Recombinant Proteins Models, Specifications, and Application
9.9.4 Eurogentec Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.9.5 Eurogentec Recent Developments
9.10 GenScript Biotech Corporation
9.10.1 GenScript Biotech Corporation Company Information, Head Office, Market Area, and Industry Position
9.10.2 GenScript Biotech Corporation Company Profile and Main Business
9.10.3 GenScript Biotech Corporation Recombinant Proteins Models, Specifications, and Application
9.10.4 GenScript Biotech Corporation Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.10.5 GenScript Biotech Corporation Recent Developments
9.11 Reprocell
9.11.1 Reprocell Company Information, Head Office, Market Area, and Industry Position
9.11.2 Reprocell Company Profile and Main Business
9.11.3 Reprocell Recombinant Proteins Models, Specifications, and Application
9.11.4 Reprocell Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.11.5 Reprocell Recent Developments
9.12 BPS Bioscience
9.12.1 BPS Bioscience Company Information, Head Office, Market Area, and Industry Position
9.12.2 BPS Bioscience Company Profile and Main Business
9.12.3 BPS Bioscience Recombinant Proteins Models, Specifications, and Application
9.12.4 BPS Bioscience Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.12.5 BPS Bioscience Recent Developments
9.13 Abnova Corporation
9.13.1 Abnova Corporation Company Information, Head Office, Market Area, and Industry Position
9.13.2 Abnova Corporation Company Profile and Main Business
9.13.3 Abnova Corporation Recombinant Proteins Models, Specifications, and Application
9.13.4 Abnova Corporation Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.13.5 Abnova Corporation Recent Developments
9.14 ProSpec Tany TechnoGene
9.14.1 ProSpec Tany TechnoGene Company Information, Head Office, Market Area, and Industry Position
9.14.2 ProSpec Tany TechnoGene Company Profile and Main Business
9.14.3 ProSpec Tany TechnoGene Recombinant Proteins Models, Specifications, and Application
9.14.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.14.5 ProSpec Tany TechnoGene Recent Developments
9.15 Ajinomoto
9.15.1 Ajinomoto Company Information, Head Office, Market Area, and Industry Position
9.15.2 Ajinomoto Company Profile and Main Business
9.15.3 Ajinomoto Recombinant Proteins Models, Specifications, and Application
9.15.4 Ajinomoto Recombinant Proteins Revenue and Gross Margin, 2021-2026
9.15.5 Ajinomoto Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
title

Table of Figures

List of Tables
 Table 1. Recombinant Proteins Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
 Table 2. Recombinant Proteins Market Restraints
 Table 3. Recombinant Proteins Market Trends
 Table 4. Recombinant Proteins Industry Policy
 Table 5. Global Recombinant Proteins Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 6. Global Recombinant Proteins Revenue Share by Company, 2021-2026, Ranked by Data of 2025
 Table 7. Global Recombinant Proteins Manufacturers Market Concentration Ratio (CR3 and HHI)
 Table 8. Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
 Table 9. Global Recombinant Proteins Major Companies Product Type
 Table 10. Head Office and Area Served of Key Players
 Table 11. Japan Recombinant Proteins Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 12. Japan Recombinant Proteins Revenue Market Share by Company, 2021-2026
 Table 13. Global Key Players of Recombinant Proteins Upstream (Raw Materials)
 Table 14. Global Recombinant Proteins Typical Customers
 Table 15. Recombinant Proteins Typical Distributors
 Table 16. by Type, Global Recombinant Proteins Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 17. by Application, Global Recombinant Proteins Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 18. By Region, Global Recombinant Proteins Consumption Value, 2021 VS 2025 VS 2032, US$ Million
 Table 19. By Region, Global Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Table 20. By Country, Global Recombinant Proteins Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 21. By Country, Global Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Table 22. By Country, Global Recombinant Proteins Consumption Value Market Share, 2021-2032
 Table 23. Bio-Techne Corporation Company Information, Head Office, Market Area, and Industry Position
 Table 24. Bio-Techne Corporation Company Profile and Main Business
 Table 25. Bio-Techne Corporation Recombinant Proteins Models, Specifications, and Application
 Table 26. Bio-Techne Corporation Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 27. Bio-Techne Corporation Recent Developments
 Table 28. Abcam PLC Company Information, Head Office, Market Area, and Industry Position
 Table 29. Abcam PLC Company Profile and Main Business
 Table 30. Abcam PLC Recombinant Proteins Models, Specifications, and Application
 Table 31. Abcam PLC Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 32. Abcam PLC Recent Developments
 Table 33. Merck KGaA Company Information, Head Office, Market Area, and Industry Position
 Table 34. Merck KGaA Company Profile and Main Business
 Table 35. Merck KGaA Recombinant Proteins Models, Specifications, and Application
 Table 36. Merck KGaA Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 37. Merck KGaA Recent Developments
 Table 38. Miltenyi Biotec Company Information, Head Office, Market Area, and Industry Position
 Table 39. Miltenyi Biotec Company Profile and Main Business
 Table 40. Miltenyi Biotec Recombinant Proteins Models, Specifications, and Application
 Table 41. Miltenyi Biotec Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 42. Miltenyi Biotec Recent Developments
 Table 43. Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
 Table 44. Thermo Fisher Scientific Company Profile and Main Business
 Table 45. Thermo Fisher Scientific Recombinant Proteins Models, Specifications, and Application
 Table 46. Thermo Fisher Scientific Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 47. Thermo Fisher Scientific Recent Developments
 Table 48. ACROBiosystems Company Information, Head Office, Market Area, and Industry Position
 Table 49. ACROBiosystems Company Profile and Main Business
 Table 50. ACROBiosystems Recombinant Proteins Models, Specifications, and Application
 Table 51. ACROBiosystems Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 52. ACROBiosystems Recent Developments
 Table 53. Sino Biological Company Information, Head Office, Market Area, and Industry Position
 Table 54. Sino Biological Company Profile and Main Business
 Table 55. Sino Biological Recombinant Proteins Models, Specifications, and Application
 Table 56. Sino Biological Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 57. Sino Biological Recent Developments
 Table 58. Cytiva Company Information, Head Office, Market Area, and Industry Position
 Table 59. Cytiva Company Profile and Main Business
 Table 60. Cytiva Recombinant Proteins Models, Specifications, and Application
 Table 61. Cytiva Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 62. Cytiva Recent Developments
 Table 63. Eurogentec Company Information, Head Office, Market Area, and Industry Position
 Table 64. Eurogentec Company Profile and Main Business
 Table 65. Eurogentec Recombinant Proteins Models, Specifications, and Application
 Table 66. Eurogentec Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 67. Eurogentec Recent Developments
 Table 68. GenScript Biotech Corporation Company Information, Head Office, Market Area, and Industry Position
 Table 69. GenScript Biotech Corporation Company Profile and Main Business
 Table 70. GenScript Biotech Corporation Recombinant Proteins Models, Specifications, and Application
 Table 71. GenScript Biotech Corporation Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 72. GenScript Biotech Corporation Recent Developments
 Table 73. Reprocell Company Information, Head Office, Market Area, and Industry Position
 Table 74. Reprocell Company Profile and Main Business
 Table 75. Reprocell Recombinant Proteins Models, Specifications, and Application
 Table 76. Reprocell Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 77. Reprocell Recent Developments
 Table 78. BPS Bioscience Company Information, Head Office, Market Area, and Industry Position
 Table 79. BPS Bioscience Company Profile and Main Business
 Table 80. BPS Bioscience Recombinant Proteins Models, Specifications, and Application
 Table 81. BPS Bioscience Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 82. BPS Bioscience Recent Developments
 Table 83. Abnova Corporation Company Information, Head Office, Market Area, and Industry Position
 Table 84. Abnova Corporation Company Profile and Main Business
 Table 85. Abnova Corporation Recombinant Proteins Models, Specifications, and Application
 Table 86. Abnova Corporation Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 87. Abnova Corporation Recent Developments
 Table 88. ProSpec Tany TechnoGene Company Information, Head Office, Market Area, and Industry Position
 Table 89. ProSpec Tany TechnoGene Company Profile and Main Business
 Table 90. ProSpec Tany TechnoGene Recombinant Proteins Models, Specifications, and Application
 Table 91. ProSpec Tany TechnoGene Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 92. ProSpec Tany TechnoGene Recent Developments
 Table 93. Ajinomoto Company Information, Head Office, Market Area, and Industry Position
 Table 94. Ajinomoto Company Profile and Main Business
 Table 95. Ajinomoto Recombinant Proteins Models, Specifications, and Application
 Table 96. Ajinomoto Recombinant Proteins Revenue and Gross Margin, US$ Million, 2021-2026
 Table 97. Ajinomoto Recent Developments


List of Figures
 Figure 1. Recombinant Proteins Picture
 Figure 2. Global Recombinant Proteins Consumption Value, (US$ million) & (2021-2032)
 Figure 3. Japan Recombinant Proteins Consumption Value, (US$ million) & (2021-2032)
 Figure 4. By Consumption Value, Japan Recombinant Proteins Market Share of Global, 2021-2032
 Figure 5. Global Recombinant Proteins Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
 Figure 6. Japan Recombinant Proteins Key Participants, Market Share, 2025
 Figure 7. Recombinant Proteins Industry Chain
 Figure 8. Recombinant Proteins Procurement Model
 Figure 9. Recombinant Proteins Sales Model
 Figure 10. Recombinant Proteins Sales Channels, Direct Sales, and Distribution
 Figure 11. Hormones
 Figure 12. Growth Factors
 Figure 13. Cytokines
 Figure 14. Plasma Protein Factor
 Figure 15. Recombinant Metabolic Enzymes
 Figure 16. Immune Checkpoint Regulators
 Figure 17. Others
 Figure 18. by Type, Global Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Figure 19. by Type, Global Recombinant Proteins Consumption Value Market Share, 2021-2032
 Figure 20. Biopharmaceutical Companies
 Figure 21. Academic and Research Institutes
 Figure 22. Contract Research Organizations
 Figure 23. by Application, Global Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Figure 24. by Application, Global Recombinant Proteins Revenue Market Share, 2021-2032
 Figure 25. By Region, Global Recombinant Proteins Consumption Value Market Share, 2021-2032
 Figure 26. North America Recombinant Proteins Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 27. By Country, North America Recombinant Proteins Consumption Value Market Share, 2025
 Figure 28. Europe Recombinant Proteins Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 29. By Country, Europe Recombinant Proteins Consumption Value Market Share, 2025
 Figure 30. Asia Pacific Recombinant Proteins Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 31. By Country/Region, Asia Pacific Recombinant Proteins Consumption Value Market Share, 2025
 Figure 32. South America Recombinant Proteins Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 33. By Country, South America Recombinant Proteins Consumption Value Market Share, 2025
 Figure 34. Middle East & Africa Recombinant Proteins Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 35. United States Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Figure 36. by Type, United States Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 37. by Application, United States Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 38. Europe Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Figure 39. by Type, Europe Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 40. by Application, Europe Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 41. China Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Figure 42. by Type, China Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 43. by Application, China Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 44. Japan Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Figure 45. by Type, Japan Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 46. by Application, Japan Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 47. South Korea Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Figure 48. by Type, South Korea Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 49. by Application, South Korea Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 50. Southeast Asia Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Figure 51. by Type, Southeast Asia Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 52. by Application, Southeast Asia Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 53. India Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Figure 54. by Type, India Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 55. by Application, India Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 56. Middle East & Africa Recombinant Proteins Consumption Value, 2021-2032, US$ Million
 Figure 57. by Type, Middle East & Africa Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 58. by Application, Middle East & Africa Recombinant Proteins Consumption Value Market Share, 2025 VS 2032
 Figure 59. Research Methodology
 Figure 60. Breakdown of Primary Interviews
 Figure 61. Bottom-up Approaches
 Figure 62. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>